Christopher Lowe

Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY.

Asante Solutions, Inc. operated as a medical device company that focuses on the management of diabetes for patients and healthcare practitioners. The firm offered Asante Snap insulin pump system (Snap system), a pump for individuals starting insulin pump therapy and for existing pumpers. The company was founded by James L. Peterson in 2006 and was headquartered in Sunnyvale, CA.

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith.

Pacific Pharmaceutical Services LLC provides virtual pharmaceutical development and warehousing services. The company is based in Reno, NV.

EpiBiome, Inc. provided microbiome engineering services. It developed EpiPhany Bacterial Profiling Service, a genomic sequencing that helps decode the chemical interactions between bacteria in microbial communities that develop better treatments. The firm served agriculture, human health, aquaculture and food safety industries. The company was founded by Aaron Tynes Hammack, Christina Tsai and Nick Conley in 2013 and was headquartered in South San Francisco, CA.

Career Closet, Inc. provides vocational counseling services. The private company is based in Smyrna, GA.

Liquid Light, Inc. develops and licenses process technology. It also develops catalysts and chemical processes for converting carbon dioxide to industrial chemicals and liquid transportation fuels. The firm specializes in the design of a technology platform that converts carbon dioxide waste into chemical products. It also focuses on leveraging clean domestic sources of energy, such as solar, wind, hydroelectric, and nuclear energy. The firm's catalyst designs are focused on helping chemical companies turn their industrial waste into a profitable source of revenue. The company was founded by Andrew Bocarsly, Narayanappa Sivasankar, Kyle Teamey and Emily Cole in 2008 and is headquartered in Monmouth Junction, NJ.

Dow Chemical Canada, Inc. manufactures chemicals and plastics products. It manufactures basic chemicals and plastics. The company's other products are ethylene glycol, polystyrene, and polyurethane resins. Dow Chemical Canada was founded in 1970 and is located in Calgary, Canada.

SentreHEART, Inc. develops catheter based solutions. Its products include products include LARIAT Suture Delivery Device, a solution for soft tissue closure; EndoCATH Occlusion Balloon, a technology for temporary occlusion and angiography; and FindrWIRZ Magnetic Guide Wire System, a solution for diagnostic and interventional procedures where control of placement and delivery is required. The company was founded by Russell Seiber, John Randall Liddicoat and William E. Cohn in 2005 and is headquartered in Redwood City, CA.

Nusano, Inc. is a privately held medical technology company that is committed to bringing stability and innovation to the medical radioisotopes market. The company is based in Valencia, CA. The company's proprietary ion source is smaller and more efficient than existing production methods, which allows for the simultaneous manufacturing of multiple radioisotopes. Nusano's state-of-the-art production facility will open in the first quarter of 2025. The company's technologies will supply the fight against cancer and support diagnostic and therapeutic radiopharmaceutical development. Christopher P. Lowe has been the CEO of the company since 2022.